
On August 26, 2024, the "US NGPs Regulation Policy and Compliance Development Workshop" organized by 2Firsts was successfully held in Shenzhen, China. The conference invited compliance policy experts from the United States and representatives from leading e-cigarette companies in China to participate. Attendees engaged in in-depth discussions on the latest trends and challenges in regulatory policies in the world's largest e-cigarette market, the U.S. market.
American Experts Explain the Latest FDA Requirements
This seminar featured several high-level experts from American compliance companies Accorto and Iner Scientific. Accorto's CEO Tom Beaudet and CSO Dr. Vincent Angelico, as well as Inter Scientific's Executive Director David Lawson and Chief Scientist Chris Corbett, delivered speeches during the event.
American experts first provided a detailed overview of the latest policy changes by the FDA regarding the review of flavored e-cigarette products, delving into core areas of scientific review such as toxicology and cancer risk assessment. They then conducted a comprehensive analysis of the standardized operational procedures and necessary review processes for the marketing of tobacco products. For example, when evaluating a product, the FDA considers the potential negative impact on public health (such as harm to minors) and potential positive impacts (such as helping adult smokers quit).
American experts have also made several suggestions for the compliant development of Chinese e-cigarette companies in the United States. For example, Chinese companies should strengthen the importance of using data to prove the compliance of their products. For instance, in terms of flavors, companies should use data to demonstrate that their products are beneficial for legal smokers and do not attract minors.
Finally, American experts emphasize that from now until January next year, it is a crucial phase for companies to comply with regulations in the US market. It is expected that regulatory policies will officially take effect in January 2025 and impact the market landscape.

Chinese Top Companies Share Actions and Challenges in Complying with US Regulations
The meeting invited several top Chinese e-cigarette companies to participate, all of which are important players in the current U.S. market. Representatives from these companies briefed on their progress in regulatory compliance in the U.S. market. Overall, it can be seen from the speeches of these representatives that top Chinese e-cigarette companies are taking U.S. regulatory requirements very seriously and have invested significant resources in the corresponding PMTA applications.
During the meeting, representatives engaged in in-depth discussions with international compliance experts on issues related to the United States' new tobacco regulatory policies. Business representatives pointed out that a major challenge they currently face is the lack of clarity in certain US regulatory policies, which makes it difficult for companies to determine the direction and intensity of their compliance efforts in the US market. They suggested that all parties should work together to further enhance communication between US market regulators and businesses, promote dialogue on regulatory policies, and help companies effectively carry out compliance efforts.
International experts engaged in lively discussions with representatives from Chinese companies, providing detailed answers to their questions. The experts commended the attending companies for their in-depth research and long-term commitment to compliance. They also expressed understanding for the challenges Chinese companies face in complying with regulations in the U.S. market, and assured that they will make every effort to facilitate improvements in these areas.
2Firsts will Continue to Support International Compliance Communication and Collaboration
At this meeting, representatives from various companies shared their experiences and challenges in compliance in the United States. The feedback from companies indicates that Chinese companies face significant industry-wide difficulties and challenges in compliance in international markets, including the US. Particularly, there is a pressing need for clearer understanding and anticipation of overseas market regulatory policies. Solving these issues cannot be achieved solely through the efforts of individual companies, requiring collective attention and efforts at the industry level.
As a leading global vaping industry media and consultancy, 2Firsts is dedicated to supporting Chinese companies in achieving high-level internationalization and expediting the compliance of global markets through professional media coverage and in-depth research, in order to contribute to the high-quality development of the global aerosol industry. In the field of policy research and compliance development, 2Firsts has conducted continuous research and investment. In July 2024, 2Firsts released the "2024 Global Novel Tobacco Regulation Report" in Chinese and English to the world, marking the first systematic annual review and analysis of global policies in the industry.

The convening of the "US NGPs Regulation Policy and Compliance Development Workshop" represents another exploration by 2Firsts in the field of international compliance exchange and collaboration. Experts and corporate representatives from China and abroad have fully recognized the significance and value of this seminar, and expressed gratitude to 2Firsts for their contributions to the event.
At the end of the meeting, Alan Zhao, co-founder and CEO of 2FIRSTS, said at the meeting: "2Firsts will carefully summarize the speeches and suggestions of the experts and business representatives present at the meeting, fully leverage 2Firsts' international influence in the media and research fields and the platform value at the industry level, to contribute to the compliance development of enterprises."
2Firsts will continue to hold global market policy seminars, welcoming experts and business representatives from both domestic and international participants. For more information, contact: info@2firsts.com, or scan the QR code.

Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.